erythromycin.pdf - ACTIVE LEARNING TEMPLATE Medication STUDENT NAME erythromycin MEDICATION 57 REVIEW MODULE CHAPTER anti-infective Pregnancy Category C

erythromycin.pdf - ACTIVE LEARNING TEMPLATE Medication...

This preview shows page 1 out of 1 page.

Unformatted text preview: ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ erythromycin MEDICATION __________________________________________________________________________ 57 REVIEW MODULE CHAPTER ___________ anti-infective Pregnancy Category C CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Suppresses protein synthesis at the level of the 50S bacterial ribosome. Therapeutic Use Bacteriostatic action against susceptible bacteria Complications CNS: seizures (rare) EENT: ototoxicity. CV: TORSADEDEPOINTES VENTRICULAR ARRHYTHMIAS QT interval prolongation. GI: PSEUDOMEMBRANOUS COLITIS nausea vomiting abdominal pain, cramping, diarrhea, hepatitis, infantile hypertrophic pyloric stenosis, pancreatitis (rare). GU: interstitial nephritis. Derm: rash Contraindications/Precautions Hypersensitivity; Concurrent use of pimozide, ergotamine, dihydroergotamine, procainamide, quinidine, dofetilide, amiodarone, or sotalol; Long QT syndrome; Hypokalemia; Hypomagnesemia; Heart rate 50 bpm/ Liver/renal disease; Interactions Concurrent use with pimozide may Increase levels and the risk for serious arrhythmias (concurrent use contraindicated); similar effects may occur with diltiazem, verapamil, ketoconazole, itraconazole, nefazodone, and protease inhibitors; avoid concurrent use Evaluation of Medication Effectiveness Resolution of the signs and symptoms of infection. Length of time for complete resolution depends on the organism and site of infection. Improvement of acne lesions ACTIVE LEARNING TEMPLATES Medication Administration (Adults): Base, stearate 250 mg q 6 hr, or 333 mg q 8 hr, or 500 mg q 12 hr. Ethylsuccinate 400 mg q 6 hr or 800 mg q 12 hr. PO (Children 1 mo): Base and ethylsuccinate 30–50 mg/kg/day divided q 6–8 hr (maximum 2 g/day as base or 3.2 g/day as ethylsuccinate) Stearate 30–50 mg/kg/day divide q6hr Nursing Interventions (maximum2g/day) PO (Neonates ):Ethylsuccinate 20– Monitor vital signs andqstate 50 mg/kg/day divided 6–12ofhr consciousness closely in IV (Adults): 250–500 mg (up to patients receiving drug for 1 g) q 6 hr. IV (Children 1mo): atropine poisoning. Since q 6 hr, 15–50 mg/kg/day divided physostigmine is usually rapidly maximum 4 g/day eliminated, patient can lapse into delirium and coma within 1 to 2 h; repeat doses may be required. Monitor closely for adverse effects related to CNS Client Education and for signs of sensitivity to physostigmine. Have atropine Instructreadily patientavailable to take for sulfate medication around the clock and clinical emergency. Discontinue to finish the drug completely as parenteral or oral drug if directed, symptoms even if feeling better. following arise: Take missed doses as soon Excessive salivation, emesis,as remembered, with or remaining frequent urination, diarrhea. doses evenly spacedsweating throughout Eliminate excessive or day. Advise patient that sharing nausea with dose reduction. of this medication may be dangerous THERAPEUTIC PROCEDURE A7 ...
View Full Document

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture